Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists-Reference-Cited by-同舟云学术

Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists

Published:2023-11 Issue:6 Volume:28 Page:101142
ISSN:1665-2681
Container-title:Annals of Hepatology
language:en
Short-container-title:Annals of Hepatology

Author:

Gracen Lucy^ORCID,Muthukumara Withma^ORCID,Aikebuse Melanie,Russell Anthony^ORCID,O'Beirne James,Irvine Katharine M.,Williams Suzanne,Puri Gaurav,Valery Patricia C.,Hayward Kelly L.,Powell Elizabeth E.

Publisher

Elsevier BV

Subject

Hepatology,General Medicine

Reference41 articles.

1. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis;Younossi;J Hepatol,2019

2. Serial transient elastography examinations to monitor patients with type 2 diabetes: a prospective cohort study;Lee;Hepatology,2020

3. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases;Chalasani;Hepatology,2018

4. European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver diseas;Sberna;Diabetic Medicine,2018

5. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease;Eslam;Hepatol Int,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ultrasound Shear Wave Elastography Evaluation of the Liver and Implications for Perioperative Medicine;Journal of Clinical Medicine;2024-06-21

2. Prevalence and Crucial Parameters in Diabesity-Related Liver Fibrosis: A Preliminary Study;Journal of Clinical Medicine;2023-12-18

3. Glucagon-Like Peptide-1 Receptor Agonists: Best Choice for Patients With Cirrhosis and Diabetes?;Clinical Gastroenterology and Hepatology;2023-09

4. Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice;Diabetes, Metabolic Syndrome and Obesity;2023-08